Mr Jory was one of the UK’s first refractive surgeons having trained initially in the early 1990’s.He has particular interests in keratoconus and post-LASIK ectasia as well as other laser refractive complications.
He was the first to train in crosslinking treatment (CXL) in the UK and is one of the first to use Intacs corneal implants.He was the first to treat presbyopia (reading glasses) with scleral implants but now prefers CK and has performed several hundred of these as well as designing instruments for these procedures.He was the first to use Phakic 6 lens implants for high myopia and hyperopia and now uses Verisyse and Veriflex lenses for these cases.
He also offers cataract surgery and refractive lens exchange with multifocal lens implants as well as astigmatic and radial keratotomy and limbal relaxing incisions.He still believes in RK having had it 17 years ago and continues to enjoy stable above average vision.As a member of the European Society of Cataract and Refractive Surgeons he has taught several of these procedures to other surgeons.
He is also on the international teaching panel of the American Society for Cataract and Refractive Surgery and reviews papers for international eye research journals as well as contributing to these.
☝ To find a top-rated laser eye surgery clinic near you, just click here to use our simple quote tool, and receive a tailored match and quote from a clinic you can trust.
Mr David Jory Reviews
I met David Jory last year when I was first diagnosed with Keratoconus. While I was still in shock and very worried about my eyes, David was so kind and reassuring. I had Crosslinking in both eyes and his patience, time and care was amazing, even after the prodcedure. I would whole heartidly recomend David to anyone with Keratoconus. He really is the best specialist I could have met and extremely so knowledgable about all things eye related.
This guy really knows his stuff and can use more than just one method of refractive surgery. He doesnt push you into a decision, gives information on risks, outcomes and likely results some of which werent available from other surgeons.